About UBS
Company Overview
UBS (ubs-coinex.com) is a financial entity registered in China, claiming incorporation on May 10, 2023. The broker's name deliberately echoes the globally recognized Swiss bank UBS, though it operates from a different jurisdiction and has no affiliation with that institution.
According to official records, UBS holds no regulatory licences from any recognized financial authority. This absence of oversight places the broker in a high-risk category for potential clients.
Regulatory Status
Our cross-checking of public registers confirms that UBS is not authorised or supervised by any major regulator such as the FCA, CySEC, ASIC, or the Monetary Authority of Singapore. The lack of regulation means there is no independent recourse for traders in the event of disputes or misconduct.
FXCanary's Scam Risk Score of 54/100 (Elevated) reflects the heightened risk associated with unregulated brokers. Traders should exercise extreme caution when considering any dealings with this entity.
Jurisdiction and Establishment
UBS is based in China and was established on May 10, 2023, making it a relatively new entrant in the financial services space. China's regulatory environment for online brokers is complex, and offshore entities often operate outside the scope of local oversight.
The broker's domain name, ubs-coinex.com, suggests a possible focus on cryptocurrency exchange services, but this has not been independently confirmed. The lack of verifiable operational history adds to the uncertainty surrounding this broker.
Available Information
Publicly available information about UBS is extremely limited. The broker's official website and collateral have not been reviewed by independent sources, leaving a significant information gap for potential investors.
Industry databases and aggregated industry data sources do not provide any user reviews or detailed product information for this entity. This dearth of transparency is itself a major red flag for cautious traders.
Risk Considerations
Given the lack of regulation, limited public information, and the use of a name that may mislead clients into associating with a reputable bank, UBS presents elevated risks. Traders should be aware that unregulated brokers offer no protection through compensation schemes or regulatory oversight.
FXCanary recommends that only those who fully understand and accept the risks of dealing with an unregulated entity should consider this broker. In most cases, traders are better served by regulated alternatives that provide a safer trading environment.
Conclusion on Transparency
The absence of independent reviews and verifiable operational details means that a comprehensive assessment of UBS is not possible at this time. Our ability to inform traders is constrained by the broker's lack of regulatory footprint and public presence.
Until such time as UBS provides clear regulatory authorisation or independently verified information, it remains a speculative and risky choice for any trader. The prudent approach is to avoid engagement with this entity.
Overview compiled by FXCanary from regulatory records and public data. full UBS review